944906-02-9

Usage

Uses

Used in Pharmaceutical Industry:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as a building block in the synthesis of pharmaceuticals for its diverse biological activities, including anti-inflammatory, anticancer, and antibacterial properties.
Used in Agrochemical Industry:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as a building block in the synthesis of agrochemicals for its potential applications in the development of new agricultural products.
Used in Materials Science:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used in materials science for its potential applications in the development of new materials.
Used as an Intermediate in Specialty Chemicals Production:
1,2,4-Oxadiazole-5-carboxaldehyde, 3-Methylis used as an intermediate in the production of specialty chemicals due to its unique structure and reactivity.

Upstream product

• 112960-56-2 (3-methyl-1,2,4-oxadiazol-5-yl)methanol 
• 40019-21-4 3-methyl-[1,2,4]oxadiazole-5-carboxylic acid ethyl ester 

Relevant academic research and scientific papers

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

1H-PYRAZOLO[4,3-B]PYRIDINES AS PDE1 INHIBITORS

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

INTEGRASE INHIBITORS 3

The present invention provides a method of treatment or prophylaxis of a viral infection in a subject comprising administering to said subject an effective amount of a compound of formula (I) or a pharmaceutically acceptable derivative, salt or prodrug thereof. Compounds of formula (I) are also provided.